Neurogene
NGNE
NGNE
84 hedge funds and large institutions have $391M invested in Neurogene in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 3.3% → 3.3% (+0.01%)
52% less call options, than puts
Call options by funds: $1.24M | Put options by funds: $2.56M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
84
Holding in Top 10
–
Calls
$1.24M
Puts
$2.56M
Top Buyers
| 1 | +$8.75M | |
| 2 | +$6.27M | |
| 3 | +$4.23M | |
| 4 |
Morgan Stanley
New York
|
+$3.36M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.76M |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$4.47M | |
| 3 | -$4.47M | |
| 4 |
SG Americas Securities
New York
|
-$1.54M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.49M |